The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

Mohammed A. Elbahloul; Aliaa Gamal; Islam Y. Elgendy

doi:10.1016/j.ejim.2026.106835

The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

Mohammed A. Elbahloul
, Aliaa Gamal
, Islam Y. Elgendy

Producción científica: Letter › revisión exhaustiva

Idioma original	English
Número de artículo	106835
Número de páginas	3
Publicación	European Journal of Internal Medicine
Volumen	150
DOI	https://doi.org/10.1016/j.ejim.2026.106835
Estado	Published - ago 2026

ASJC Scopus subject areas

Internal Medicine

Acceder al documento

10.1016/j.ejim.2026.106835

Otros archivos y enlaces

Citar esto

@article{c3b1d56898134b5aa119923d442bea95,

title = "The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia",

keywords = "Enlicitide, Hypercholesterolemia, Oral PCSK9 Inhibitor, meta-analysis",

author = "Elbahloul, \{Mohammed A.\} and Aliaa Gamal and Elgendy, \{Islam Y.\}",

year = "2026",

month = aug,

doi = "10.1016/j.ejim.2026.106835",

language = "English",

volume = "150",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

AU - Elbahloul, Mohammed A.

AU - Gamal, Aliaa

AU - Elgendy, Islam Y.

PY - 2026/8

Y1 - 2026/8

KW - Enlicitide

KW - Hypercholesterolemia

KW - Oral PCSK9 Inhibitor

KW - meta-analysis

UR - https://www.scopus.com/pages/publications/105032666250

UR - https://www.scopus.com/pages/publications/105032666250#tab=citedBy

U2 - 10.1016/j.ejim.2026.106835

DO - 10.1016/j.ejim.2026.106835

M3 - Letter

AN - SCOPUS:105032666250

SN - 0953-6205

VL - 150

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

M1 - 106835

ER -

The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto